Detection Method:Sandwich
Test principle:This assay employs a two-site sandwich ELISA to quantitate MAP1LC3A in samples. An antibody specific for MAP1LC3A has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyMAP1LC3A present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for MAP1LC3A is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of MAP1LC3A bound in the initial step. The color development is stopped and the intensity of the color is measured.
Product Overview:MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene.The deduced 121-amino acid protein shares 81% identity with rat Map1lc3. Northern blot analysis detected a 1.1-kb transcript in most tissues examined, with highest expression in heart, brain, liver, skeletal muscle, and testis. No MAP1LC4A expression was detected in thymus and peripheral blood leukocytes.
